Aclaris Therapeutics, Inc.

Q2 2019 13F Holders

Symbol
ACRS
CUSIP
00461U105
Type
Equity
Class
COM
Num filings
92
Total reported value, excl. options
$78.8 M
Manager Report Date Value ($000) Shares Option Type